Advocates and lawmakers are racing against a looming September deadline to prevent a “funding cliff” for critical amyotrophic lateral…
Articles by Marisa Wexler, MS
People living with amyotrophic lateral sclerosis (ALS) in the U.S. generally prefer care models where they can see multiple…
Early treatment with AL-S Pharma‘s infusion therapy AP-101 significantly extended survival and delayed the need for respiratory support…
An analysis of how polarized light interacts with clumps of proteins in the eyes may help differentiate amyotrophic lateral…
A Phase 2 clinical trial showed that early treatment with the experimental oral therapy PrimeC slowed functional decline and reduced…
A brain implant to detect attempted finger movements can enable people paralyzed by conditions such as amyotrophic lateral sclerosis…
Insmed has launched a first-in-human clinical trial evaluating its experimental gene therapy INS1202 in people with amyotrophic lateral…
An experimental nerve-protecting therapy called RT1999 (smilagenin) will soon be tested in people with amyotrophic lateral sclerosis (ALS)…
People with amyotrophic lateral sclerosis (ALS) who were exposed to smoke from wildfires prior to developing the disease are…
The ALS Network will continue to host its ASK ME…